Charmacy Pharmaceutical Co., Ltd.

2289

CNE1000023D6

Drug Retailers

Market Closed - Hong Kong S.E. Other stock markets 04:08:22 2024-04-29 am EDT			5-day change	1st Jan Change
13.8 ^HKD	-1.00%		+39.82%	+6.48%

Apr. 01	Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains	MT
Mar. 28	Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024	CI

Charmacy Pharmaceutical : EXCHANGE NOTICE - TRADING HALT

October 17, 2021 at 09:02 pm EDT

Listed Company Information

EXCHANGE NOTICE - TRADING HALT
Trading in the H shares (stock code: 02289) of Charmacy Pharmaceutical Co., Ltd. will be halted at 9:00 a.m. today (18/10/2021).

Attachments

Original document
Permalink

Disclaimer

Charmacy Pharmaceutical Co. Ltd. published this content on 18 October 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 18 October 2021 01:01:03 UTC.

Latest news about Charmacy Pharmaceutical Co., Ltd.

Charmacy Pharmaceutical 2023 Profit Declines on Lower Asset Disposal Gains	Apr. 01	MT
Charmacy Pharmaceutical Co., Ltd. Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 10 July 2024	Mar. 28	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 28	CI
Charmacy Pharmaceutical’s Profit to Drop by 45% in 2023	Mar. 18	MT
Charmacy Pharmaceutical Meets Minimum Public Float Norms	23-09-04	MT
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Charmacy Pharmaceutical Co., Ltd. Approves Final Dividend for the Year Ended 31 December 2022, Payable on 31 July 2023	23-06-05	CI
Charmacy Pharmaceutical Chairman Steps Down	23-05-31	MT
Charmacy Pharmaceutical Co., Ltd. Announces Board Changes	23-05-31	CI
Charmacy Pharmaceutical Co., Ltd. Announces Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on July 31, 2023	23-05-25	CI
Charmacy Pharmaceutical's Controlling Shareholder Signs Letter of Commitment for Director Appointment; Shares Climb 6%	23-04-19	MT
Charmacy Pharmaceutical Co., Ltd. Announces Resignation of Executives	23-04-18	CI
Charmacy Pharmaceutical Co., Ltd. Recommends Ordinary Final Dividend for the Year Ended 31 December 2022, Payable on 20 July 2023	23-03-31	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-31	CI
Charmacy Pharmaceutical Renews Loan Provision Deal with Controlling Shareholder	23-03-03	MT
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders.	23-02-09	CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. completed the acquisition of 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong.	23-01-16	CI
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.	23-01-16	CI
Charmacy Pharmaceutical Forecasts Increase in January-November Net Profit	22-12-20	MT
Charmacy Pharmaceutical Co., Ltd. Provides Financial Guidance for the 11 Months Ended 30 November 2022	22-12-20	CI
Charmacy Pharmaceutical to Surrender Land Use Right on Property in China for $22.3 Million	22-10-12	MT
Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. agreed to acquire 9% of stake in Charmacy Pharmaceutical Co., Ltd. from Yao Chuanglong for HKD 70.9 million.	22-09-27	CI
Charmacy Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-31	CI
Charmacy Pharmaceutical Co., Ltd. Announces Executive Changes	22-07-13	CI
Charmacy Pharmaceutical Approves Re-Appointment of Shinewing Certified Public Accountants as the Auditors	22-06-06	CI

Chart Charmacy Pharmaceutical Co., Ltd.

Duration

Period

More charts

Company Profile

Charmacy Pharmaceutical Co., Ltd. is principally engaged in pharmaceutical products distribution in the Peopleâs Republic of China (the PRC). The products also include healthcare medicine, traditional Chinese drinking tablets, traditional Chinese medicine and medical equipment. Through its subsidiaries, the Company is also engaged in the trading of pharmaceutical products and provision of related services.

Sector

Drug Retailers

Calendar

2024-08-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
CHARMACY PHARMACEUTICAL CO., LTD.	+6.48%	192M
WALGREENS BOOTS ALLIANCE, INC.	-32.21%	15.27B
JD HEALTH INTERNATIONAL INC.	-29.67%	10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-28.54%	6.06B
YIFENG PHARMACY CHAIN CO., LTD.	+8.14%	6.04B
MATSUKIYOCOCOKARA & CO.	-11.41%	5.86B
NAHDI MEDICAL COMPANY	-1.17%	4.69B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+52.19%	4.29B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-14.86%	3.33B
WELCIA HOLDINGS CO., LTD.	-6.93%	3.01B

Other Drug Retailers

Charmacy Pharmaceutical Co., Ltd.

Equities

2289

CNE1000023D6

Drug Retailers

Charmacy Pharmaceutical : EXCHANGE NOTICE - TRADING HALT

Latest news about Charmacy Pharmaceutical Co., Ltd.

Chart Charmacy Pharmaceutical Co., Ltd.

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Drug Retailers